The role of intratumoral therapy with cisplatin/epinephrine injectable gel in the management of advanced squamous cell carcinoma of the head and neck

Archives of Otolaryngology - Head and Neck Surgery

Volumn 128, Issue 8, 2002, Pages 880-885

  Wenig, Barry L ^a   Werner, Jochen A ^b   Castro, Dan J ^c   Sridhar, Kasi S ^d   Garewal, Harinder S ^e   Kehrl, Wolfgang ^f   Pluzanska, Anna ^g   Arndt, Olaf ^h   Costantino, Peter D ⁱ   Mills, Glenn M ^j   Dunphy Ii, Frank R ^k,m   Orenberg, Elaine K ^l   Leavitt, Richard D ^l  

^a NORTHWESTERN UNIVERSITY   (United States)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^g MEDICAL UNIVERSITY OF LODZ   (Poland)

^h UNIVERSITY OF REGENSBURG   (Germany)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^j LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^k SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l Columbia University College of Physicians and Surgeons ^*  (United States)

^m DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CISPLATIN; PLACEBO;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; GEL; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SQUAMOUS CELL CARCINOMA; TARGET CELL; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 0036337842     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.128.8.880     Document Type: Article

References (24)

1. Head and neck cancer
2. The surgical pathology of head and neck cancer
3. The national cancer data base report on cancer of the head and neck
4. Estimates of the worldwide incidence of 25 major cancers in 1990
5. Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Current status and future directions
6. The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck
7. Injectable modalities as local and regional strategies for head and neck cancer
8. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck
9. Cisplatin
10. Influence of treatment sequence on efficacy of fluorouracil and cisplatin intratumoral drug delivery in vivo
11. Intralesional cisdiamminedichloroplatinum and purified collagen treatment of human metastatic malignancies: A feasibility study
12. Endoscopic treatment of gastric cancer with intratumoral cisplatin/epinephrine injectable gel: A case report
13. Intralesional cisplatin for the treatment of cutaneous B-cell lymphoma
14. Intratumoral cisplatin/epinephrine injectable gel as a palliative treatment for accessible solid tumors: A multicenter pilot study
15. Phase III trials of intratumoral cisplatin/epinephrine injectable gel for treatment of advanced solid tumors
16. A new instrument to assess improvements in quality of life (QoL) attributed to local control of head and neck squamous cell carcinoma (HNSCC)
17. Validation of the Treatment Goals Questionnaire® (TGQ): A new instrument to assess patient benefit following treatment of squamous cell carcinoma of the head and neck (HNSCC) with intratumoral cisplatin/epinephrine injectable gel
18. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study
19. Randomized comparison of cisplatin, methotrexate, bleomycin, and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastastic squamous cell carcinoma of the head and neck: A phase III study of the EORTC Head and Neck Cancer Cooperative Group
20. Performance data and survival in head and neck cancer
21. Measuring quality of life in palliative care
22. Collagen matrix cisplatin prevents local tumor growth after margin-positive resection
23. Radiosensitization by intratumoral administration of cisplatin in a sustained-release drug delivery system